These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15146007)

  • 1. Correlation between clinical characteristics and proliferative activity in patients with craniopharyngioma.
    Losa M; Vimercati A; Acerno S; Barzaghi RL; Mortini P; Mangili F; Terreni MR; Santambrogio G; Giovanelli M
    J Neurol Neurosurg Psychiatry; 2004 Jun; 75(6):889-92. PubMed ID: 15146007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of the MIB-1 labeling index for patient with craniopharyngioma.
    Nishi T; Kuratsu J; Takeshima H; Saito Y; Kochi M; Ushio Y
    Int J Mol Med; 1999 Feb; 3(2):157-61. PubMed ID: 9917523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of human MCM6 and DNA Topo II alpha in craniopharyngiomas and its correlation with recurrence of the tumor.
    Xu J; Zhang S; You C; Huang S; Cai B; Wang X
    J Neurooncol; 2007 Jun; 83(2):183-9. PubMed ID: 17410335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferative activity in craniopharyngiomas: clinicopathological correlations in adults and children.
    Raghavan R; Dickey WT; Margraf LR; White CL; Coimbra C; Hynan LS; Rushing EJ
    Surg Neurol; 2000 Sep; 54(3):241-7; discussion 248. PubMed ID: 11118571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical detection of female sex hormone receptors in craniopharyngiomas: correlation with clinical and histologic features.
    Izumoto S; Suzuki T; Kinoshita M; Hashiba T; Kagawa N; Wada K; Fujimoto Y; Hashimoto N; Saitoh Y; Maruno M; Yoshimine T
    Surg Neurol; 2005 Jun; 63(6):520-5; discussion 525. PubMed ID: 15936368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do craniopharyngioma molecular signatures correlate with clinical characteristics?
    Omay SB; Chen YN; Almeida JP; Ruiz-Treviño AS; Boockvar JA; Stieg PE; Greenfield JP; Souweidane MM; Kacker A; Pisapia DJ; Anand VK; Schwartz TH
    J Neurosurg; 2018 May; 128(5):1473-1478. PubMed ID: 28707994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
    Roser F; Samii M; Ostertag H; Bellinzona M
    Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ki-67 labeling is correlated with the time to recurrence in primary glioblastomas.
    Schröder R; Feisel KD; Ernestus RI
    J Neurooncol; 2002 Jan; 56(2):127-32. PubMed ID: 11995813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MIB-1 immunoreactivity in craniopharyngiomas: a clinico-pathological analysis.
    Duò D; Gasverde S; Benech F; Zenga F; Giordana MT
    Clin Neuropathol; 2003; 22(5):229-34. PubMed ID: 14531547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinico-pathological and immunohistochemical characteristics associated to recurrence/regrowth of craniopharyngiomas.
    Tena-Suck ML; Salinas-Lara C; Arce-Arellano RI; Rembao-Bojórquez D; Morales-Espinosa D; Sotelo J; Arrieta O
    Clin Neurol Neurosurg; 2006 Oct; 108(7):661-9. PubMed ID: 16500745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors for craniopharyngioma recurrence: a systematic review and illustrative case report of a rapid recurrence.
    Prieto R; Pascual JM; Subhi-Issa I; Jorquera M; Yus M; Martínez R
    World Neurosurg; 2013; 79(5-6):733-49. PubMed ID: 22892136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of cyclin A and cyclin B1 proteins in astrocytomas.
    Allan K; Jordan RC; Ang LC; Taylor M; Young B
    Arch Pathol Lab Med; 2000 Feb; 124(2):216-20. PubMed ID: 10656729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minichromosome maintenance protein 7 as prognostic marker of tumor aggressiveness in pituitary adenoma patients.
    Coli A; Asa SL; Fadda G; Scannone D; Chiloiro S; De Marinis L; Lauretti L; Ranelletti FO; Lauriola L
    Eur J Endocrinol; 2016 Mar; 174(3):307-14. PubMed ID: 26620390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic indicators in a range of astrocytic tumours: an immunohistochemical study with Ki-67 and p53 antibodies.
    Ellison DW; Steart PV; Bateman AC; Pickering RM; Palmer JD; Weller RO
    J Neurol Neurosurg Psychiatry; 1995 Oct; 59(4):413-9. PubMed ID: 7561922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade.
    Nakamura N; Yamamoto H; Yao T; Oda Y; Nishiyama K; Imamura M; Yamada T; Nawata H; Tsuneyoshi M
    Hum Pathol; 2005 Jul; 36(7):828-37. PubMed ID: 16084954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Markers of cell division cycle in glioblastoma: significance in prediction of treatment response and patient prognosis.
    Yousaf J; Hills C; Dixit S; Achawal S; O'Brien D; Greenman J; Scott IS
    Br J Neurosurg; 2013 Dec; 27(6):752-8. PubMed ID: 23477614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cell cycle regulator p27Kip1 is correlated with survival of patients with astrocytoma.
    Mizumatsu S; Tamiya T; Ono Y; Abe T; Matsumoto K; Furuta T; Ohmoto T
    Clin Cancer Res; 1999 Mar; 5(3):551-7. PubMed ID: 10100706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radical excision of pediatric craniopharyngioma: recurrence pattern and prognostic factors.
    Kim SK; Wang KC; Shin SH; Choe G; Chi JG; Cho BK
    Childs Nerv Syst; 2001 Sep; 17(9):531-6; discussion 537. PubMed ID: 11585327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonfunctioning pituitary adenomas: association of Ki-67 and HMGA-1 labeling indices with residual tumor growth.
    Šteňo A; Bocko J; Rychlý B; Chorváth M; Celec P; Fabian M; Belan V; Šteňo J
    Acta Neurochir (Wien); 2014 Mar; 156(3):451-61; discussion 461. PubMed ID: 24452592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.